Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
Mo | IMAC Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
25.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
18.03. | Jorge Ruiz, Investor bei IMAC Holdings, erwirbt Aktien in 2 US-Dollar Transaktion | 1 | Investing.com Deutsch | ||
IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
18.03. | IMAC Holdings-Investor Jorge Ruiz verkauft Aktien im Wert von 15.000 US-Dollar | 1 | Investing.com Deutsch | ||
14.03. | IMAC Holdings-Investor Jorge Ruiz verkauft Stammaktien im Wert von 5.273 US-Dollar | 1 | Investing.com Deutsch | ||
14.03. | Jorge Ruiz, bedeutender Aktionär von IMAC Holdings, verkauft Aktien im Wert von 39.954 US-Dollar | - | Investing.com Deutsch | ||
07.03. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
28.02. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
19.02. | IMAC Holdings, Inc.: Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay | 1 | GlobeNewswire (USA) | ||
12.02. | IMAC Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
11.02. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
10.02. | IMAC Holdings, Inc.: Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response | 1 | GlobeNewswire (USA) | ||
28.01. | Pre-market Movers: IMAC Holdings, Planet Image International, SAB Biotherapeutics, MicroCloud Hologram, Avalon Holdings | 602 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green IMAC Holdings, Inc. (BACK) is up over 91% at $1.59.
Planet... ► Artikel lesen | |
28.01. | Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket | 6 | Benzinga.com | ||
27.01. | IMAC Holdings, Inc.: IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies | 129 | GlobeNewswire (Europe) | Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to... ► Artikel lesen | |
24.01. | IMAC Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
17.01. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
20.12.24 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
18.12.24 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,770 | 0,00 % | PLUS THERAPEUTICS, INC. - 10-K, Annual Report | ||
LIFEWARD | 1,570 | -7,10 % | Lifeward Ltd.: FDA Issues Clearance for ReWalk 7 Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
EKSO BIONICS | 0,370 | -7,04 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
IMUNON | 0,900 | -2,17 % | Imunon, Inc.: IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3... ► Artikel lesen | |
ROCKWELL MEDICAL | 0,999 | +7,37 % | ROUNDUP/Aktien New York: Erneute Dow-Verluste - Nasdaq-Rally pausiert | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Anders als zuletzt wird der US-Leitindex dabei aber von den anderen US-Indizes... ► Artikel lesen | |
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
VIRIDIAN THERAPEUTICS | 11,500 | +0,88 % | Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data | WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare... ► Artikel lesen | |
SINTX TECHNOLOGIES | 2,500 | 0,00 % | Pre-market Movers: Sintx Technologies, Cycurion, OSR Holdings, ReShape Lifesciences, NewGenIvf Group | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.35 A.M. ET).In the Green Sintx Technologies, Inc. (SINT) is up over 87%... ► Artikel lesen | |
AETHLON MEDICAL | 0,430 | -100,00 % | XFRA DIVERSE INSTRUMENTE: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCASTOR MARITIME... ► Artikel lesen | |
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
NEURONETICS | 3,325 | +1,68 % | Neuronetics: Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression | ||
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
HVIVO | 0,146 | +5,80 % | ILiAD Biotechnologies, LLC: ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting | Trial anticipated for H2 2025 to evaluate most advanced next generation intranasal pertussis vaccine for whooping cough
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most... ► Artikel lesen | |
FRESENIUS | 39,710 | +0,53 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.04.2025 / 14:14... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,520 | -7,15 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Siemens Healthineers auf "Buy" mit einem Kursziel von 67 Euro belassen. Der Medizintechnikkonzern dürfte solide Quartalszahlen vorlegen und... ► Artikel lesen |